BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 28545225)

  • 1. State of Art of Cancer Pharmacogenomics in Latin American Populations.
    López-Cortés A; Guerrero S; Redal MA; Alvarado AT; Quiñones LA
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28545225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics: ethnicity, treatment and health in Latin American populations.
    Sosa-Macías M; Fricke-Galindo I; Fariñas H; Monterde L; Ruiz-Cruz ED; Molina-Guarneros J; Tarazona-Santos E; Rodrigues-Soares F; Galaviz-Hernández C; Peñas-Lledó E; Moya G; Lara-Riegos J; Terán E; Hernández I; Ramírez-Roa R; Altamirano-Tinoco C; López-López M; García-Ortiz JE; LLerena A
    Pharmacogenomics; 2023 Jun; 24(9):489-492. PubMed ID: 37529900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conference scene: Latin American Pharmacogenomics and Personalized Medicine Conference.
    Suarez-Kurtz G
    Pharmacogenomics; 2012 Oct; 13(13):1449-52. PubMed ID: 23057544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer pharmacogenomics: implications on ethnic diversity and drug response.
    Patel JN
    Pharmacogenet Genomics; 2015 May; 25(5):223-30. PubMed ID: 25751395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perception of the usefulness of drug/gene pairs and barriers for pharmacogenomics in Latin America.
    Quinones LA; Lavanderos MA; Cayun JP; Garcia-Martin E; Agundez JA; Caceres DD; Roco AM; Morales JE; Herrera L; Encina G; Isaza CA; Redal MA; Larovere L; Soria NW; Eslava-Schmalbach J; Castaneda-Hernandez G; Lopez-Cortes A; Magno LA; Lopez M; Chiurillo MA; Rodeiro I; Castro de Guerra D; Teran E; Estevez-Carrizo F; Lares-Assef I
    Curr Drug Metab; 2014 Feb; 15(2):202-8. PubMed ID: 24524664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics, biomarker network, and allele frequencies in colorectal cancer.
    López-Cortés A; Paz-Y-Miño C; Guerrero S; Jaramillo-Koupermann G; León Cáceres Á; Intriago-Baldeón DP; García-Cárdenas JM; Guevara-Ramírez P; Armendáriz-Castillo I; Leone PE; Quiñones LA; Cayún JP; Soria NW
    Pharmacogenomics J; 2020 Feb; 20(1):136-158. PubMed ID: 31616044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Diversity in Pharmacogenetics: A Latin American Perspective.
    Suarez-Kurtz G; Parra EJ
    Adv Pharmacol; 2018; 83():133-154. PubMed ID: 29801573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.
    Naranjo MG; Rodrigues-Soares F; Peñas-Lledó EM; Tarazona-Santos E; Fariñas H; Rodeiro I; Terán E; Grazina M; Moya GE; López-López M; Sarmiento AP; Calzadilla LR; Ramírez-Roa R; Ortiz-López R; Estévez-Carrizo FE; Sosa-Macías M; Barrantes R; LLerena A;
    OMICS; 2018 Sep; 22(9):575-588. PubMed ID: 30183544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Pharmacogenomics: Does It Matter If You're Black or White?
    De T; Park CS; Perera MA
    Annu Rev Pharmacol Toxicol; 2019 Jan; 59():577-603. PubMed ID: 30296897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic ancestry, admixture and health determinants in Latin America.
    Norris ET; Wang L; Conley AB; Rishishwar L; Mariño-Ramírez L; Valderrama-Aguirre A; Jordan IK
    BMC Genomics; 2018 Dec; 19(Suppl 8):861. PubMed ID: 30537949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic Variation and Its Clinical Relevance in a Latin American Rural Population.
    Olloquequi J; Castro-Santos P; Díaz-Peña R
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics and ethnicity: relevance for clinical implementation, clinical trials, pharmacovigilance and drug regulation in Latin America.
    Sosa-Macías M; Teran E; Waters W; Fors MM; Altamirano C; Jung-Cook H; Galaviz-Hernández C; López-López M; Remírez D; Moya GE; Hernández F; Fariñas H; Ramírez R; Céspedes-Garro C; Tarazona-Santos E; LLerena A
    Pharmacogenomics; 2016 Nov; 17(16):1741-1747. PubMed ID: 27790935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
    Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
    Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes.
    Muyambo S; Ndadza A; Soko ND; Kruger B; Kadzirange G; Chimusa E; Masimirembwa CM; Ntsekhe M; Nhachi CFB; Dandara C
    OMICS; 2022 Jan; 26(1):35-50. PubMed ID: 34958284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of Antiretroviral Drug Response and Pharmacokinetic Variations in Indigenous South African Populations.
    O'Connell KS; Swart M; McGregor NW; Dandara C; Warnich L
    OMICS; 2018 Sep; 22(9):589-597. PubMed ID: 30235109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomic biomarkers for personalized cancer treatment.
    Rodríguez-Antona C; Taron M
    J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics in Latin American populations: regulatory aspects, application to herbal medicine, cardiovascular and psychiatric disorders.
    Rodeiro I; Remírez-Figueredo D; García-Mesa M; Dorado P; LLerena A;
    Drug Metabol Drug Interact; 2012; 27(1):57-60. PubMed ID: 22718626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution and linkage disequilibrium of the enhancer SNP rs5758550 among Latin American populations: influence of continental ancestry.
    Elias ABR; Araújo GS; de Souza SJ; Suarez-Kurtz G
    Pharmacogenet Genomics; 2020 Jun; 30(4):67-72. PubMed ID: 32187157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics in the age of personalized medicine.
    Dickmann LJ; Ware JA
    Drug Discov Today Technol; 2016; 21-22():11-16. PubMed ID: 27978982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics of neuropsychiatric disorders: analysis of genetic variability in 162 identified neuroreceptors using 1000 Genomes Project data.
    Kaur H; Jajodia A; Grover S; Agarwal N; Baghel R; Kukreti R
    Pharmacogenomics; 2014; 15(12):1575-87. PubMed ID: 25340732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.